Connect with us
[ad_1] The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of...
[ad_1] Aachen, Germany, 22 October 2024 – Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a...
[ad_1] ANN ARBOR, Mich., July 13, 2023 (Newswire.com) – The University of Michigan and Applied Dynamics International (ADI) are pleased to announce the successful phase 1...
[ad_1] AFROJACK, CALVIN HARRIS, ILLENIUM, NERVO, NGHTMRE, SKRILLEX to headline the Main Stage. ADAM BEYER, AMELIE LENS, SASHA & JOHN DIGWEED to lead Resistance. ULTRA Abu...